OSF HealthCare has expanded its use of Rapid AI's stroke-detection software from its flagship hospitals to OSF St. Joseph Medical Center in Bloomington and rural hospitals across its Illinois network, letting neurologists review brain scans on their phones and speed up treatment decisions.
French robotics company Wandercraft commercially launched Eve on September 17, 2026, the first FDA-cleared self-balancing personal exoskeleton available to wheelchair users with spinal cord injuries at any neurological level, powered by AI trained on billions of simulated and real-world steps.
The FDA has granted 510(k) clearance to iHealthScreen's iPredict-DR, an AI screening tool paired with the iCare DRSplus fundus camera that lets primary care staff detect diabetic retinopathy without an ophthalmologist on site.
The FDA has cleared the Targeted Real-Time Early Warning System (TREWS), an AI tool born out of Johns Hopkins research and commercialized by Bayesian Health, marking the first authorized device that flags sepsis risk before clinicians even suspect it, with data showing an 18% cut in in-hospital mortality across dozens of U.S. hospitals.
Boston-based GenHealth.ai has raised a $16.5 million Series A led by Flare Capital Partners to expand its AI agents that automate prior authorization, billing, denials, and appeals for medical practices, bringing its total funding to $30 million.
Youper, an AI-powered emotional health app founded in 2016 that grew to more than 3 million users, will stop working on September 30, 2026 and delete all user data October 1 after years without meaningful funding beyond a single 2019 seed round.
Oura's integration with Counsel Health lets ring members chat with medical AI and escalate to a licensed physician inside the app, and on September 17, 2026 Counsel said it will extend AI-native chronic-care management to Medicare beneficiaries through the CMS ACCESS Model starting in early 2027.
Ultrahuman raised a $70 million round led by Qualcomm Ventures on September 3, 2026, valuing the Indian wearables startup at $365 million as it works with Qualcomm on a future ring that runs on-device AI rather than just tracking sleep and recovery.
The FDA's new TEMPO pilot lets four digital health companies, including Limbic's AI voice therapy agent Unpacked, reach Medicare patients and gather real-world outcomes data before seeking full marketing authorization.
NVIDIA and Eli Lilly are investing up to $1 billion over five years in a San Francisco Bay Area AI co-innovation lab that pairs robotic wet labs with NVIDIA's BioNeMo and Vera Rubin computing platforms to run round-the-clock drug experiments.